论文部分内容阅读
目的探讨利凡诺联合米非司酮在中期妊娠引产的临床效果。方法 77例中期妊娠引产患者被随机分为实验组和对照组。对照组单用利凡诺,实验组给予联合用药方案。结果两组患者引产成功率差异无统计学意义,但实验组在用药至宫缩时间、用药至排胎时间、总产程、出血量、胎盘胎膜滞留率、术后行清宫术等指标方面均显著优于对照组(P<0.05)。结论利凡诺联合米非司酮应用于中止中期妊娠,可更为有效地引发宫颈扩张,降低胎盘、胎膜残留率,缩短胎儿娩出时间,减少患者痛苦和相关并发症,改善产后恢复,是值得在临床上考虑的引产方案之一。
Objective To investigate the clinical efficacy of Rivanol in combination with mifepristone in induction of labor during the second trimester of pregnancy. Methods 77 cases of mid-pregnancy induced labor were randomly divided into experimental group and control group. Control group alone rivanol, experimental group given combination regimen. Results There was no significant difference in the successful rate of induction of labor between the two groups. However, in the experimental group, there were no significant differences in the indexes of induction of labor between the two groups in terms of medication time to contractions, time to delivery, time to delivery, volume of bleeding, retention rate of placenta, Significantly better than the control group (P <0.05). Conclusions Rivarox combined with mifepristone in the prevention of mid-term pregnancy can be more effective in inducing cervical dilatation, reducing placental and fetal membrane residual rates, shortening the time of delivery of the fetus, reducing patient pain and related complications, and improving postpartum recovery. It is worth considering in the clinical one of the induction of labor.